Catherine Hill
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Papers in
- Oncology 51
- Global Cancer Incidence and Screening 23
-
- Pain Management and Opioid Use 14
- Co-authors
- Serge Koscielny (8 shared papers)Stefan Michiels (7 shared papers)Naguib A. Samaan (10 shared papers)Jean‐Pierre Pignon (6 shared papers)Michael L. Ibañez (7 shared papers)Monique G. Lê (8 shared papers)Cédric Mahé (2 shared papers)Bertrand BAUJAT (2 shared papers)
- Journals
- The Lancet (20 papers)Cancer (14 papers)British Journal of Cancer (14 papers)Physical Review Letters (12 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Catherine Hill
250 papers receiving 33.1k citations
Catherine Hill's Hit Papers
Peers
Comparison fields: 5 of 219
- Infectious Diseases 4.1k
- Cancer Research 3.1k
- Health 1.4k
- Oncology 3.5k
- Otorhinolaryngology 556
Countries citing papers authored by Catherine Hill
This map shows the geographic impact of Catherine Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Hill more than expected).
Fields of papers citing papers by Catherine Hill
This network shows the impact of papers produced by Catherine Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Hill. The network helps show where Catherine Hill may publish in the future.
Co-authors
The 25 scholars most cited alongside Catherine Hill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 273 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 7189 |
| 2 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 6758 |
| 3 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3621 |
| 4 | Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Hit paper breakdown → | 1998 | 1919 |
| 5 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 867 |
| 6 | Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials Hit paper breakdown → | 2017 | 844 |
| 7 | Prediction of cancer outcome with microarrays: a multiple random validation strategy Hit paper breakdown → | 2005 | 792 |
| 8 | The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: Estimates of Radiation-Related Cancer Risks Hit paper breakdown → | 2007 | 561 |
| 9 | A graphical method for exploring heterogeneity in meta‐analyses: application to a meta‐analysis of 65 trials Hit paper breakdown → | 2002 | 549 |
| 10 | 2005 | 474 | |
| 11 | Systematic Review of the Epidemiology of Complicated Peptic Ulcer Disease: Incidence, Recurrence, Risk Factors and Mortality Hit paper breakdown → | 2011 | 407 |
| 12 | 1984 | 330 | |
| 13 | 1981 | 322 | |
| 14 | 2003 | 311 | |
| 15 | 1978 | 309 | |
| 16 | 2019 | 306 | |
| 17 | 1970 | 275 | |
| 18 | Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials Hit paper breakdown → | 2021 | 241 |
| 19 | 1983 | 228 | |
| 20 | 1984 | 218 |
About Catherine Hill
Catherine Hill is a scholar working on Oncology, Anesthesiology and Pain Medicine, Cancer Research, Nuclear and High Energy Physics and Endocrinology, Diabetes and Metabolism, having authored 273 papers that have together received 34.9k indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (23 papers), Particle physics theoretical and experimental studies (20 papers), Breast Cancer Treatment Studies (17 papers), Thyroid Cancer Diagnosis and Treatment (15 papers), High-Energy Particle Collisions Research (14 papers), Pain Management and Opioid Use (14 papers), Quantum Chromodynamics and Particle Interactions (14 papers) and Radiation Dose and Imaging (13 papers). The work is most often cited by research in Infectious Diseases (4.1k citations), Cancer Research (3.1k citations), Health (1.4k citations), Oncology (3.5k citations) and Otorhinolaryngology (556 citations). Catherine Hill has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Serge Koscielny, Stefan Michiels, Naguib A. Samaan, Jean‐Pierre Pignon, Michael L. Ibañez, Monique G. Lê, Cédric Mahé, Bertrand BAUJAT, R Flamant and Robert C. Hickey. Their work appears in journals such as The Lancet, Cancer, British Journal of Cancer, Physical Review Letters and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.